Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid

Next Previous
Trial Profile

Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid

Status: Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perflubutane (Primary)
  • Indications Liver cancer
  • Focus Diagnostic use

Most Recent Events

  • 12 Sep 2017 Planned initiation date changed from 1 Mar 2017 to 1 Oct 2017.
  • 12 Sep 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
  • 29 Mar 2017 Planned initiation date changed from 1 Mar 2016 to 1 Mar 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top